期刊文献+

^(125)Ⅰ粒子装载过程中工作人员受照剂量的研究 被引量:10

Radiation dose accepted by operators during loadingⅠ seeds
下载PDF
导出
摘要 目的:研究125I粒子装载过程中工作人员受照剂量。方法:选择测量粒子为前列腺癌治疗所用的14.8MBq的125I粒子,测量粒子周围的剂量率,按照平均装载速度及前列腺癌平均的植入粒数86粒,评估125I粒子装载过程中工作人员的受照剂量。结果:在无屏蔽防护情况下,操作人员全身有可能受到高于剂量限值的照射。不同的操作方式,操作人员手部的受照剂量不同,分批倒出粒子装载可以降低手部的受照剂量,分批装载次数越多,手部的受照剂量越低。结论:建议在125I粒子装载中,在L型铅防护屏下或防护通风橱中进行,以降低全身剂量;采用分多次装载的方法,以降低手部的剂量。 Objective: To investigate the radiation dose accepted by operators during loading the ^125Ⅰ seeds to the seeds cells of the implantation gun. Method: The seeds for prostate cancer therapy were selected. The radioactivity of a seed was 14.8MBq. The radiation dose caused by an ^125Ⅰseed was measured and the radiation dose accepted by operators during loading the ^125Ⅰseeds was evaluated according to the average loading speed and the average seeds number for a patient with prostate cancer. Results: The operators may accept the exposure exceeding the dose limit for occupational exposure without any shield protection. The hands of the operator accepted different exposure dose with different loading procedure. The dose decreased by dividing the seeds into several groups for loading. The more the batches for loading the lower the dose. Conclussion: Loading ^125Ⅰ seeds with shield protection and more groups is suggested to reduce the radiation dose accepted by operators.
出处 《中国医学装备》 2012年第10期1-3,共3页 China Medical Equipment
基金 国家自然科学基金(30270408)"肿瘤核素内照射适形治疗的逆向计划系统及实验研究" 北京希望马拉松专项基金(LC2009B43)"125Ⅰ粒子植入的质量控制及放射防护的研究"
关键词 碘放射性同位素 辐射剂量 粒子装载 Iodine radioisotopes Radiation dose Loading
  • 相关文献

参考文献10

  • 1张春霆(综述),徐勇(审校).^125I粒子植入治疗前列腺癌研究进展[J].国际泌尿系统杂志,2011,31(5):649-653. 被引量:2
  • 2Morris WJ,Keyes M,Palma D. Evaluation of dosimetric parameters and disease response after 125 iodine transperineal brachytherapy for low-and intermediate-risk prostate cancer[J].International Journal of Radiation Oncology,Biology,Physics,2009,(05):1432-1438.
  • 3Gómez-Iturriaga Pi?a A,Crook J,Borg J. Median 5 year follow-up of 125iodine brachytherapy as monotherapy in men aged《or=55 years with favorable prostate cancer[J].Urology,2010,(06):1412-1416.
  • 4Pereira da Ponte Amadei L,Fernandes Silva JL,Hanna SA. Biochemical control of prostate cancer with iodine-125 brachytherapy alone:experience from a single institution[J].Clin Transl Oncol,2012,(05):369-375.
  • 5王俊杰,黄毅,冉维强,朱丽红,白静,田素青,李金娜.^(125)I粒子近距离治疗前列腺癌临床应用[J].中华放射医学与防护杂志,2004,24(6):509-512. 被引量:38
  • 6Jarusevicius L,Inciura A,Juozaityte E. Comparison of Implant Quality between Loose and Intra-operatively Linked Iodine-125 Seeds in Prostate Cancer Brachytherapy[J].Journal of Radiation Research,2012,(03):439-446.
  • 7卫生部.低能γ射线粒子源植入治疗的放射防护与质量控制检测规范[S],2006.
  • 8国家质量监督检验检疫总局.电离辐射防护与辐射源安全基本标准[S],2002.
  • 9刘运祚.常用放射性核素衰变纲图[M]北京:原子能出版社,1982.
  • 10陈克敏;王忠敏.放射性粒子植入技术临床应用[M]北京:科学出版社,2011.

二级参考文献19

  • 1陈明,孙则禹,张古田,陈恕求,李俊龙,彭涛,戴玉田.经会阴^(125)I粒子组织间植入治疗局限性前列腺癌临床研究(附10例报告)[J].现代泌尿外科杂志,2007,12(2):101-103. 被引量:7
  • 2Pasteau O, Degrais P. The radium treatment of cancer of the prnstate. Arch Roentgen Ray, 1914,28:396.
  • 3Whitmore WFJR, Hilaris B, Grabstald H. Retropubic implantation of i- odine 125 in the treatment of prostatic cancer. J Urol, 1972 : 108 - 118.
  • 4NAG S, BEYER D, FRIEDLAND J, et al. American Brachytherapy Society (ABS)reeomm -endations fox transperienal permanent brachytherapy of prostate cancer. Lnt J Radiat Oncol Biol Phys, 1999, 44 (4) :789 -799.
  • 5Holm HH, Juul N, Pedersen JF, et al. Transperineal 1252iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. J Urol ,1983,130:283 -286.
  • 6Nag S, BryerD, Friedland J, et al. American Brachytherpy Society (ABS) recommendations for transperienal permanent brachytherpy of prostate cancer. Int J Radiat Onc Biol Phys, 1999,44:789 - 799.
  • 7Grimm PD, Blasko JC, Sylvester JE et al. 10 - year biochemical ( prostate - specific antigen) control of prostate cancer with ( 125 ) 1 brachytherapy[ J]. Int J Radiat Oncol Biol Phys,2001,51 ( 1 ) :31 40.
  • 8Morris WJ, Keyes M, Palma D. et al. Evaluation of dosimetric param- eters and disease response after 125 iodine transperineal brachythera- py for low - and intermediate - risk prostate cancer, Int J Radiat On- col Biol Phys. 2009 Apr 1 ;73(5) :1432 - 1438.
  • 9Stock RG, Cahlon O, Cesaretti JA,et al. Stone NNCombined modality treatment in the management of high - risk prostate cancer. Int J Radi- at Oncol Biol Phys,2004,59 ( 5 ) : 1352 - 1359.
  • 10Gomez - Iturriaga Pia A, Crook J, Borg J, et al. Median 5 year fol- low - up of 125iodine brachytherapy as monotherapy in men aged < or = 55 years with favorable prostate cancer. Urology ,2010,75 ( 6 ) : 1412 -1416.

共引文献37

同被引文献79

引证文献10

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部